Bionano Genomics Inc (BNGO)
0.224
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
0.2184
-0.01
(-2.50%)
After-Hours: 17:44
Bionano Genomics Shareholders Equity (Quarterly): 48.87M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 48.87M |
| June 30, 2024 | 80.34M |
| March 31, 2024 | 82.77M |
| December 31, 2023 | 96.16M |
| September 30, 2023 | 119.00M |
| June 30, 2023 | 214.76M |
| March 31, 2023 | 231.49M |
| December 31, 2022 | 249.40M |
| September 30, 2022 | 281.74M |
| June 30, 2022 | 284.73M |
| March 31, 2022 | 311.18M |
| December 31, 2021 | 337.12M |
| September 30, 2021 | 341.56M |
| June 30, 2021 | 345.87M |
| Date | Value |
|---|---|
| March 31, 2021 | 362.72M |
| December 31, 2020 | 35.08M |
| September 30, 2020 | 14.68M |
| June 30, 2020 | 5.837M |
| March 31, 2020 | -4.213M |
| December 31, 2019 | 3.614M |
| September 30, 2019 | -7.378M |
| June 30, 2019 | -1.345M |
| March 31, 2019 | 5.870M |
| December 31, 2018 | 10.14M |
| September 30, 2018 | 15.24M |
| June 30, 2018 | -57.28M |
| March 31, 2018 | -54.02M |
| December 31, 2017 | -50.23M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.213M
Minimum
Mar 2020
362.72M
Maximum
Mar 2021
172.13M
Average
166.88M
Median
Shareholders Equity (Quarterly) Benchmarks
| Revvity Inc | 7.922B |
| Bruker Corp | 1.807B |
| Azenta Inc | 1.769B |
| Harvard Bioscience Inc | 65.32M |
| Akoya Biosciences Inc | 13.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 87.36M |
| Total Liabilities (Quarterly) | 38.49M |
| Debt to Equity Ratio | 0.306 |
| Current Ratio | 1.426 |
| Net Debt Paydown Yield | -7.45% |